Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 5/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28253727 | 0.93 | ALDH1A1 (0.45) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL28452989 | 0.89 | GAA (0.38) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL1712950 | 0.87 | MAPT (0.46) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL16269329 | 0.85 | GRIN2D (0.60) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL26217996 | 0.84 | POLB (0.62) | GAAPOLBALDH1A1KMT2AMEN1 | |
| SCHEMBL3231322 | 0.84 | GRIN2D (0.40) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL237474 | 0.84 | GRIN2D (0.56) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL602378 | 0.79 | ALDH1A1 (0.52) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL23539449 | 0.78 | — | — | |
| SCHEMBL14696231 | 0.76 | ALDH1A1 (0.42) | GAAGRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111304931-A | Wear-resistant flame-retardant floor leather for vehicles and preparation method thereof | 朱冬梅 | 2020-06-19 | — | — | CN | claimed |
| US-4321265-A | 7α-Methoxycephalosporins | TOYAMA CHEMICAL CO., LTD. (JP) | 1982-03-23 | — | — | US | claimed |
| EP-4705279-A1 | RADICALLY POLYMERISABLE COMPOUND AND COMPOSITION | Mühlbauer Technology GmbH (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20250215256-A1 | POLYMER FILM-FORMING COMPOSITION AND SELECTIVE POLYMER FILM-FORMING METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-12318459-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2025-06-03 | — | — | US | disclosed |
| EP-4503100-A1 | POLYMER FILM-FORMING COMPOSITION AND SELECTIVE POLYMER FILM-FORMING METHOD | Nissan Chemical Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024227533-A1 | RADICALLY POLYMERISABLE COMPOUND AND COMPOSITION | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2024-11-07 | — | — | WO | disclosed |
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | disclosed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | disclosed |
| EP-1962141-A2 | Electrostatic image developing toner, method for producing same, electrostatic image developer, image forming method and image forming apparatus | Fuji Xerox Co., Ltd. (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-20080199798-A1 | Electrostatic image developing toner, method for producing same, electrostatic image developer, image forming method and image forming apparatus | FUJI XEROX CO., LTD. (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080038646-A1 | Resin particle dispersion liquid, toner for developing electrostatic image and method for producing the same, developer for developing electrostatic image, and method for forming image | FUJI XEROX CO., LTD. (JP) | 2008-02-14 | — | — | US | disclosed |
| US-20070287088-A1 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070243478-A1 | Electrostatic image developing toner, electrostatic image developer, image forming method, image forming apparatus and printed matter | FUJI XEROX CO., LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
| EP-0053621-B1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM | BATTELLE MEMORIAL INSTITUTE (CH) | 1984-07-25 | — | — | EP | disclosed |
| EP-0053621-A1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM. | BATTELLE MEMORIAL INSTITUTE (CH) | 1982-06-16 | — | — | EP | disclosed |
| US-4332964-A | Unsaturated esters of adamantane containing diols and thermo-resistant cross-linked polymers therefrom | BATTELLE DEVELOPMENT CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| WO-1981003657-A1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM | BATTELLE MEMORIAL INSTITUTE (CH) | 1981-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | PUF60, POLQ, F10 | GAA 2939/4885GRIN2D 1587/4885GRIN3B 2057/4885 |
| US-12318459-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | GAA 2939/4885GRIN2D 1587/4885GRIN3B 2057/4885 |
| US-20070287088-A1 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | RCC1, BET1, BRI3BP | GAA 3211/4885GRIN2D 1285/4885GRIN3B 2393/4885 |
| US-11944692-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | GAA 2939/4885GRIN2D 1587/4885GRIN3B 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.